$0.55
+0.04 (+6.94%)
Open$0.52
Previous Close$0.51
Day High$0.58
Day Low$0.52
52W High$4.56
52W Low$2.04
Volume—
Avg Volume212.9K
Market Cap14.12M
P/E Ratio19.64
EPS$0.17
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+583.6% upside
Current
$0.55
$0.55
Target
$3.76
$3.76
$2.62
$3.76 avg
$5.13
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 7.84M | 7.68M | 7.81M |
| Net Income | -2,005,672 | -1,738,578 | -1,581,297 |
| Profit Margin | -25.6% | -22.6% | -20.2% |
| EBITDA | -2,263,216 | -2,551,790 | -2,649,024 |
| Free Cash Flow | -1,406,564 | -1,071,377 | -1,645,390 |
| Rev Growth | +12.8% | +0.1% | +6.4% |
| Debt/Equity | 0.17 | 0.20 | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |